Aair Research Center

Rochester, New York 14618

0 studies enrolling now · 40 studies all time

What they study most

Agammaglobulinemia, Antibody Deficiency, Arthritis, Arthritis, Rheumatoid, Asthma, Autoimmune Diseases, COPD, Chronic Low Back Pain, Chronic Obstructive Pulmonary Disease, Chronic Pain, Chronic Sinusitis, Dry Mouth Associated With Sjogren's Syndrome

Studies at this site

• Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) — Completed
• Tanezumab In Osteoarthritis Of The Knee (2) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• Open-label Extension Study Of RN624 — Completed
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis — Completed
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome — Completed
• PF-00489791 For The Treatment Of Raynaud's — Completed
• Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX — Completed
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate — Completed
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• PF-06372865 In Subjects With Chronic Low Back Pain — Completed
• Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma — Completed
• Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis — Completed
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) — Stopped early
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• Efficacy and Safety/Tolerability of Grass MATA MPL — Completed
• Efficacy and Safety/Tolerability of Ragweed MATA MPL — Completed
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early
• Amphotericin B Suspension in Refractory Chronic Sinusitis — Completed
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease — Completed